Horizon Pharma (NASDAQ: HZNP) announced a collaboration with the Alliance for Lupus Research (ALR) to study RAYOS (prednisone) delayed-release tablets ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Linden Disruption Expected to Have 'Minimal Impact' on Horizon Pharma (HZNP) - MizuhoNovember 11, 2015 11:57 AM Horizon Pharma plc Announces Collaboration With Alliance for Lupus Research to Study RAYOS(R) (prednisone) Delayed-Release Tablets in Systemic Lupus ErythematosusNovember 11, 2015 7:01 AM